Cited by 80Atrial Fibrillation Management and OutcomesNon-Invasive Vital Sign MonitoringBlood Pressure and Hypertension Studies

Comparison of the Microlife Blood Pressure Monitor With the Omron Blood Pressure Monitor for Detecting Atrial Fibrillation

Wiesel, Joseph, Arbesfeld, Benjamin, Schechter, David·2014·The American Journal of Cardiology

Abstract

Screening for atrial fibrillation (AF) by assessing the pulse is recommended in high-risk patients. Some clinical trials demonstrated that the Microlife blood pressure monitor (BPM) with AF detection is more accurate than pulse palpation. This led to a change in practice guidelines in the United Kingdom where AF screening with the Microlife device is recommended instead of pulse palpation. Many BPMs have irregular heart beat detection, but they have not been shown to detect AF reliably. Recently, one study, in a highly select population, suggested that the Omron BPM with irregular heart beat detection has a higher sensitivity for AF than the Microlife BPM. We compared the Microlife and Omron BPMs to electrocardiographic readings for AF detection in general cardiology patients. Inclusion criteria were age≥50 years without a pacemaker or defibrillator. A total of 199 subjects were enrolled, 30 with AF. Each subject had a 12-lead electrocardiography, 1 Omron BPM reading, and 3 Microlife BPM readings as per device instructions. The Omron device had a sensitivity of 30% (95% confidence interval [CI] 15.4% to 49.1%) with the sensitivity for the first Microlife reading of 97% (95% CI 81.4% to 100%) and the Microlife readings using the majority rule (AF positive if at least 2 of 3 individual readings were positive for AF) of 100% (95% CI 85.9% to 100%). Specificity for the Omron device was 97% (95% CI 92.5% to 99.2%) and for the first Microlife reading of 90% (95% CI 83.8% to 94.2%) and for the majority rule Microlife device of 92% (95% CI 86.2% to 95.7%; p<0.0001). The specificity of both devices is acceptable, but only the Microlife BPM has a sensitivity value that is high enough to be used for AF screening in clinical practice.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2014.07.016

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Weisel et al., Omron HeartScan had 30% sensitivity and 97% specificity for detection of atrial fibrillation.

    “In a study by Weisel J et al14 the sensitivity for detection of atrial fibrillation was low, that is, 30%, and specificity was high, that is, 97%.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wiesel, J., Arbesfeld, B., & Schechter, D.
Affiliations
  • NYU Langone Health (US)
  • Long Island Jewish Medical Center (US)
  • New York Hospital Queens (US)
Corresponding author
Wiesel, Joseph
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2014-10
Volume
114
Issue
7
Pages
1046-1048
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2071400403
Cited by
80
References
12
Citations by year
2026: 1 · 2025: 5 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 16 · 2020: 5 · 2019: 6 · 2018: 10 · 2017: 12 · 2016: 10 · 2015: 2
FWCI
5.49
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
atrial fibrillation, blood pressure monitors, Omron, pulse palpation, AF screening, sensitivity and specificity, electrocardiogram, majority rule, high-risk patients
MeSH terms
Aged, Aged, 80 and over, Atrial Fibrillation, Blood Pressure, Electrocardiography, Equipment Design, Female, Heart Rate, Humans, Male, Middle Aged, Sensitivity and Specificity, Reproducibility of Results, Blood Pressure Monitors, Blood Pressure Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review